Discount Agreements for Bevacizumab and Rituximab
GWQ ServicePlus AG is entering into non-exclusive discount agreements for Bevacizumab and Rituximab to optimize the drug supply for statutory health insurance funds starting July 1, 2026.
CONTRACTING AUTHORITY
Name
GWQ ServicePlus AG
City
Düsseldorf
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
LOTS (2)
Rabattvereinbarung für Bevacizumab
Rabattvereinbarung für Rituximab
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
713 days remaining(LOT-0001)
Published